Literature DB >> 11689625

Vaccinia virus infection disarms the mitochondrion-mediated pathway of the apoptotic cascade by modulating the permeability transition pore.

S T Wasilenko1, A F Meyers, K Vander Helm, M Barry.   

Abstract

Many viruses have evolved strategies that target crucial components within the apoptotic cascade. One of the best studied is the caspase 8 inhibitor, crmA/Spi-2, encoded by members of the poxvirus family. Since many proapoptotic stimuli induce apoptosis through a mitochondrion-dependent, caspase 8-independent pathway, we hypothesized that vaccinia virus would encode a mechanism to directly modulate the mitochondrial apoptotic pathway. In support of this, we observed that Jurkat cells, which undergo Fas-mediated apoptosis exclusively through the mitochondrial route, were resistant to Fas-induced death following infection with a crmA/Spi-2-deficient strain of vaccinia virus. In addition, vaccinia virus-infected cells subjected to the proapoptotic stimulus staurosporine exhibited decreased levels of both cytochrome c released from the mitochondria and caspase 3 activation. In all cases we found that the loss of the mitochondrial membrane potential, which occurs as a result of opening the multimeric permeability transition pore complex, was prevented in vaccinia virus-infected cells. Moreover, vaccinia virus infection specifically inhibited opening of the permeability transition pore following treatment with the permeability transition pore ligand atractyloside and t-butylhydroperoxide. These studies indicate that vaccinia virus infection directly impacts the mitochondrial apoptotic cascade by influencing the permeability transition pore.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11689625      PMCID: PMC114730          DOI: 10.1128/JVI.75.23.11437-11448.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  72 in total

1.  A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2.

Authors:  V S Goldmacher; L M Bartle; A Skaletskaya; C A Dionne; N L Kedersha; C A Vater; J W Han; R J Lutz; S Watanabe; E D Cahir McFarland; E D Kieff; E S Mocarski; T Chittenden
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

2.  Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1beta-converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1beta-induced fever.

Authors:  S Kettle; A Alcamí; A Khanna; R Ehret; C Jassoy; G L Smith
Journal:  J Gen Virol       Date:  1997-03       Impact factor: 3.891

Review 3.  BCL-2 family: regulators of cell death.

Authors:  D T Chao; S J Korsmeyer
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

4.  Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked.

Authors:  J Yang; X Liu; K Bhalla; C N Kim; A M Ibrado; J Cai; T I Peng; D P Jones; X Wang
Journal:  Science       Date:  1997-02-21       Impact factor: 47.728

5.  Simultaneous imaging of cell and mitochondrial membrane potentials.

Authors:  D L Farkas; M D Wei; P Febbroriello; J H Carson; L M Loew
Journal:  Biophys J       Date:  1989-12       Impact factor: 4.033

6.  Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential.

Authors:  Z Rahmani; K W Huh; R Lasher; A Siddiqui
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

7.  African swine fever virus gene A179L, a viral homologue of bcl-2, protects cells from programmed cell death.

Authors:  A Brun; C Rivas; M Esteban; J M Escribano; C Alonso
Journal:  Virology       Date:  1996-11-01       Impact factor: 3.616

8.  Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor.

Authors:  F Q Hu; C A Smith; D J Pickup
Journal:  Virology       Date:  1994-10       Impact factor: 3.616

9.  The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins.

Authors:  I Marzo; C Brenner; N Zamzami; S A Susin; G Beutner; D Brdiczka; R Rémy; Z H Xie; J C Reed; G Kroemer
Journal:  J Exp Med       Date:  1998-04-20       Impact factor: 14.307

10.  Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo.

Authors:  N Zamzami; P Marchetti; M Castedo; C Zanin; J L Vayssière; P X Petit; G Kroemer
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

View more
  19 in total

Review 1.  Poxvirus immunomodulatory strategies: current perspectives.

Authors:  J B Johnston; Grant McFadden
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

2.  Myxoma and vaccinia viruses exploit different mechanisms to enter and infect human cancer cells.

Authors:  Nancy Y Villa; Eric Bartee; Mohamed R Mohamed; Masmudur M Rahman; John W Barrett; Grant McFadden
Journal:  Virology       Date:  2010-03-24       Impact factor: 3.616

3.  The vaccinia virus F1L protein interacts with the proapoptotic protein Bak and inhibits Bak activation.

Authors:  Shawn T Wasilenko; Logan Banadyga; David Bond; Michele Barry
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

4.  Vaccinia virus F1L protein is a tail-anchored protein that functions at the mitochondria to inhibit apoptosis.

Authors:  Tara L Stewart; Shawn T Wasilenko; Michele Barry
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  Structural insight into BH3 domain binding of vaccinia virus antiapoptotic F1L.

Authors:  Stephanie Campbell; John Thibault; Ninad Mehta; Peter M Colman; Michele Barry; Marc Kvansakul
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

6.  Increased protection from vaccinia virus infection in mice genetically prone to lymphoproliferative disorders.

Authors:  Mina O Seedhom; Keisha S Mathurin; Sung-Kwon Kim; Raymond M Welsh
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

7.  Sheeppox virus SPPV14 encodes a Bcl-2-like cell death inhibitor that counters a distinct set of mammalian proapoptotic proteins.

Authors:  Toru Okamoto; Stephanie Campbell; Ninad Mehta; John Thibault; Peter M Colman; Michele Barry; David C S Huang; Marc Kvansakul
Journal:  J Virol       Date:  2012-08-15       Impact factor: 5.103

8.  Vaccinia Virus Encodes a Novel Inhibitor of Apoptosis That Associates with the Apoptosome.

Authors:  Melissa R Ryerson; Monique M Richards; Marc Kvansakul; Christine J Hawkins; Joanna L Shisler
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

9.  CD8 T cells use IFN-γ to protect against the lethal effects of a respiratory poxvirus infection.

Authors:  John Goulding; Georges Abboud; Vikas Tahiliani; Pritesh Desai; Tarun E Hutchinson; Shahram Salek-Ardakani
Journal:  J Immunol       Date:  2014-04-18       Impact factor: 5.422

10.  Vaccinia virus F1L interacts with Bak using highly divergent Bcl-2 homology domains and replaces the function of Mcl-1.

Authors:  Stephanie Campbell; Bart Hazes; Marc Kvansakul; Peter Colman; Michele Barry
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.